The Health Department has defended its R15.5bn AIDS drug tender against a legal challenge from pharmaceutical manufacturer Cipla. The department argues that officials followed a fair and rational process when awarding contracts to supply key HIV medicines. The dispute centres on contracts that took effect on 1 December 2025. They cover the daily treatment used by most HIV patients. Cipla,…
Tag: Drug Procurement
-
HIV Prevention Shot Lenacapavir: Aspen Warns of Demand Risks
South Africa’s leading generic drug manufacturer, Aspen Pharmacare, has issued a stark warning regarding the local production of a breakthrough medical treatment. The company asserts that local firms require guaranteed demand to manufacture the HIV prevention shot lenacapavir sustainably. South Africa was notably absent from the initial round of voluntary licences. In 2024, the patent holder, Gilead Sciences, awarded licences…
-
Botswana Medicine Shortages Expose Deep Procurement Failures
Across Botswana, patients are growing used to a sentence that lands like a warning. “Ga gona molemo.” Your medication is out of stock. For mothers at clinics, elderly patients and people living with chronic illness, the phrase signals more than inconvenience. It means interrupted treatment, rising anxiety and, in some cases, worsening health. Health experts and former officials say the…